Literature DB >> 19850202

Skin type classification systems old and new.

Wendy E Roberts1.   

Abstract

The history of classifying skin types is rather new and there has been considerable progress made with continuing awareness. The Fitzpatrick Skin Phototype Classification remains the gold standard. It is simple and user friendly, however this system fails to accurately predict skin reactions. The Roberts Skin Type Classification System is a tool to predict the skin response to injury and insult from cosmetic procedures and identify the propensity of sequelae from inflammatory skin disorders. It can be a predictor of an impending complication, such as hyperpigmentation and scarring, which can then be avoided. In addition, it includes the skin phototype and photoage. In evaluating patients' skin and developing a cosmetic plan, the four indices outlined in this article, hyper/hypopigmentation risk, scarring risk, skin phototype, and photoage, are crucial to identify for optimal outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19850202     DOI: 10.1016/j.det.2009.08.006

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  38 in total

Review 1.  Shining light on skin pigmentation: the darker and the brighter side of effects of UV radiation.

Authors:  Nityanand Maddodi; Ashika Jayanthy; Vijayasaradhi Setaluri
Journal:  Photochem Photobiol       Date:  2012-04-12       Impact factor: 3.421

2.  Association of skin color, race/ethnicity, and hearing loss among adults in the USA.

Authors:  Frank R Lin; Paige Maas; Wade Chien; John P Carey; Luigi Ferrucci; Roland Thorpe
Journal:  J Assoc Res Otolaryngol       Date:  2011-11-29

3.  Making sense of skin color in clinical care.

Authors:  Janine S Everett; Mia Budescu; Marilyn S Sommers
Journal:  Clin Nurs Res       Date:  2012-05-28       Impact factor: 2.075

4.  Effect of fat on serum 25-hydroxyvitamin D levels after a single oral dose of vitamin D in young healthy adults: a double-blind randomized placebo-controlled study.

Authors:  Fabiana Viegas Raimundo; Maria Augusta Britto Lang; Luciano Scopel; Natália Aydos Marcondes; Mirna Griselda Anocibar Araújo; Gustavo Adolpho Moreira Faulhaber; Tania Weber Furlanetto
Journal:  Eur J Nutr       Date:  2014-05-23       Impact factor: 5.614

5.  Are the Fitzpatrick Skin Phototypes Valid for Cancer Risk Assessment in a Racially and Ethnically Diverse Sample of Women?

Authors:  Marilyn S Sommers; Jamison D Fargo; Yadira Regueira; Kathleen M Brown; Barbara L Beacham; Angela R Perfetti; Janine S Everett; David J Margolis
Journal:  Ethn Dis       Date:  2019-07-18       Impact factor: 1.847

6.  Combination therapy using non-ablative fractional laser and intralesional triamcinolone injection for hypertrophic scars and keloids treatment.

Authors:  Jongweon Shin; Jin Tae Cho; Song I Park; Sung No Jung
Journal:  Int Wound J       Date:  2019-09-02       Impact factor: 3.315

7.  Comparing the effects of 3 different pressure ulcer prevention support surfaces on the structure and function of heel and sacral skin: An exploratory cross-over trial.

Authors:  Tsenka Tomova-Simitchieva; Andrea Lichterfeld-Kottner; Ulrike Blume-Peytavi; Jan Kottner
Journal:  Int Wound J       Date:  2017-12-26       Impact factor: 3.315

Review 8.  [Intense pulsed light (IPL) as a therapeutic option for Meibomian gland dysfunction].

Authors:  A Schuh; S Priglinger; E M Messmer
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

9.  Radiodermatitis prevention with sucralfate in breast cancer: fundamental and clinical studies.

Authors:  Sabrina Falkowski; Patrick Trouillas; Jean-Luc Duroux; Jean-Marie Bonnetblanc; Pierre Clavère
Journal:  Support Care Cancer       Date:  2009-12-09       Impact factor: 3.603

10.  Vitamin D and parameters of calcium homeostasis in inpatients with and without Type 2 diabetes mellitus.

Authors:  V Carnevale; M Inglese; M A Annese; A De Matthaeis; S A Santini; V Frusciante; A Fontana; M Copetti; F Pellegrini; G D'Amico
Journal:  J Endocrinol Invest       Date:  2012-01-30       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.